Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Gushengtang Holdings's Debt-to-EBITDA or its related term are showing as below:
FRA:F2P'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -7.87 Med: -0.01 Max: 1.24
Current: 1.24
During the past 8 years, the highest Debt-to-EBITDA Ratio of Gushengtang Holdings was 1.24. The lowest was -7.87. And the median was -0.01.
FRA:F2P's Debt-to-EBITDA is ranked better than 65.27% of 478
companies
in the Healthcare Providers & Services industry
Industry Median: 2.195
vs FRA:F2P: 1.24
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Gushengtang Holdings Debt-to-EBITDA Related Terms
Gushengtang Holdings Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Gushengtang Holdings's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:F2P vs HCA, THC, DVA: Debt-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Gushengtang Holdings's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gushengtang Holdings Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Gushengtang Holdings's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Gushengtang Holdings's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is two times the quarterly (Dec. 2025) EBITDA data.
Gushengtang Holdings (FRA:F2P) has a Debt-to-EBITDA of 1.09 as of Dec. 2025. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Gushengtang Holdings. According to the industry distribution chart, Gushengtang Holdings ranks #166 out of 478 companies in the Healthcare Providers & Services industry, placing it in the top 34.7%.
Is Gushengtang Holdings' Debt-to-EBITDA too high?
Gushengtang Holdings' current Debt-to-EBITDA is 1.09. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.20. Gushengtang Holdings' value of 1.09 is 50.3% below this industry median. Based on the distribution chart, Gushengtang Holdings ranks #166 out of 478 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Gushengtang Holdings has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Gushengtang Holdings' Debt-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Gushengtang Holdings ranks #166 out of 478 companies for Debt-to-EBITDA. This puts Gushengtang Holdings in the upper half of its industry. The industry median Debt-to-EBITDA is 2.20. Gushengtang Holdings' value of 1.09 is 50.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.20, based on 478 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gushengtang Holdings's current Debt-to-EBITDA of 1.09 is 50.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Gushengtang Holdings. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gushengtang Holdings's current Debt-to-EBITDA is 1.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gushengtang Holdings stock overvalued right now?
Gushengtang Holdings (FRA:F2P) has a current Debt-to-EBITDA of 1.09. The stock's GF Value™ is €6.40, compared to a current price of €2.94 — trading 54.1% below its estimated fair value. The current Debt-to-EBITDA is 1.09 and 50.3% below the Healthcare Providers & Services industry median of 2.20. Gushengtang Holdings' overall GF Score™ is 88/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Gushengtang Holdings (FRA:F2P), the current Debt-to-EBITDA is 1.09 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gushengtang Holdings (FRA:F2P) Overvalued in 2026?
Based on GuruFocus' analysis, Gushengtang Holdings stock appears to be undervalued.
The current stock price of €2.94 is trading 54.1% below its estimated GF Value™ of €6.40.
Key valuation signals for FRA:F2P:
Debt-to-EBITDA: 1.09
GF Value™: €6.40 vs. price of €2.94 (54.1% below fair value)
Industry Position: 50.3% below the Healthcare Providers & Services median (#166 of 478)
No single metric tells the full story. See the FRA:F2P stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gushengtang Holdings Ltd is a traditional chinese medicine (TCM) company. Through offline medical institutions and online healthcare platforms, it provides customers with a comprehensive range of TCM healthcare services and products to address diverse medical and healthcare management needs. All of the group's revenue is derived from the PRC.
88GF Score
Get the complete analysis for FRA:F2P
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:F2P has been successfully added to your 
